动脉粥样硬化的分子核医学研究进展

黄代娟; 张永学

动脉粥样硬化的分子核医学研究进展

黄代娟 , 张永学

文章导航 > 国际放射医学核医学杂志 > 2007, 31 > 5: (264-266,273)

引用本文:

Citation:

动脉粥样硬化的分子核医学研究进展

430022 武汉, 华中科技大学同济医学院附属协和医院核医学科, 湖北省分子影像学重点实验室
中图分类号: R817.4

The development of molecular nuclear medicine in atherosclerosis

Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Key Laboratory of Molecular Imaging, Wuhan 430022, China
CLC number: R817.4

摘要: 动脉粥样硬化涉及到全身多处重要的动脉,是导致成人死亡的主要原因之一.早期诊断动脉粥样硬化斑块尤其是不稳定斑块具有重要的临床意义.该疾病病理生理学的不断发展,显示出包括"金标准"X射线血管造影在内的常用显像方法的一些不足以及对更加完善的显像技术的需求.分子核医学技术利用核素标记参与动脉粥样硬化形成的中间物质或其表面的血栓进行显像,无创伤性地检测斑块的数量、进展程度、分布和组成,为早期发现动脉粥样硬化提供了可靠依据.
- 动脉硬化 /
- 放射性核素显像 /
- 分子诊断技术
Abstract: Atherosclerosis involves many essential arteries of whole body and it is one of the main diseases that lead adults to death. So it has clinical significance to diagnose atherosclerosis in early stage and to judge its instability. Recent advances in the pathohiology of atherosclerosis have highlighted the inadequacies of the current techniques including the gold standard of X-ray angiography and the need for better imaging approaches. Molecular nuclear medicine can noninvasively detect the number, extent, distribution and component of atherosclerotic plaque, through nuclide imaging with the middle substances during the atherosclerotic process or thrombus on the surface of plaque, and thus can diagnose atherosclerosis in time.
- Atherosclerosis /
- Radionuclide imaging /
- Molecular diaghotic techniques
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	张艳容.动脉粥样硬化斑块显像研究进展.国外医学·放射医学核医学分册,2004,28(3):109-113.
[2]	Lederman R J, Rayhnan RR, Fisher SJ, et al. Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG). Nucl Med Colnmun, 2001, 22(7):747-753.
[3]	Yun M, Yell D, Araujo LI, et al. F-18 FDG uptake in the large arteries:a new observatiou. Clin Nucl Med, 2001, 26(4):314-319.
[4]	Hanif MZ, Ghesani M, Shah AA, et al. F-18 fluorodeoxyglucose uptake in atheroselerotic plaque in the mediastinum mimicking malignancy:another potential for error. Clin Nucl Med, 2004, 29(2):93-95.
[5]	Rudd JH, Warburton EA, Fryer TD, et al. Imaging atherosclerotic plaque inflammation with[¹⁸F]-fluorodeoxyglucose positron emission tomography. Circulatiml, 2002, 105(23):2708-2711.
[6]	Ogawa M, Ishino S, Mukai T, et al. (18)F-FDG accumulation in atherosclerotic plaques:immunohistochemical and PET imaging study. J Nucl Med, 2004, 45(7):1245-1250.
[7]	Davies JR, Rudd JH, Flyer TD, et al. Identification of culprit lesions after transient ischemic attack by combined ¹⁸F fluorodeoxyglucose positron-emission tomography and high-resolutlon magnetic resonance imaging. Stroke, 2005, 36(12):2642-2647.
[8]	Hardoff R. Zanzonieo P. Braegehnann F, et al. Localization of (99m) Tc-labeled ApoB synthetic peptide in arterial lesions of an experimental model of spontaneous atheroselerosis. Am J Ther, 1995, 2(2):88-99.
[9]	Bugiardini R, Manfrini O, Pizzi C, et al. Endothelial function predicls future development of coronary artery disease:a study of women with chest pain and normal coronary angiograms. Circulation, 2004, 109(21):2518-2523.
[10]	Tepe G, Duda SH. Meding J, et al. Tc-99m-labeled endothelin derivative for imaging of experimentally induced atherosclerosis. Atherosclerosis, 2001, 157(2):383-392.
[11]	Sakuma T, Sklenar J, Leong-Poi H, et al. Molecular imaging identifies regions with microthromboemboli during primaly angioplasty in acute coronary thrombosis. J Nucl Med, 2004; 45(7):1194-1200.
[12]	Elmaleh DR, Napala J, Babich JW, et al. Rapid noninvasive detection of experimental atherosclerotic lesion with novel ^99mTc-labeled diadenosine tetraphosphates. Proc Natl Acad Sci USA,1998, 95(2):691-695.
[13]	Tsinlikas S. Noninvasive imaging of oxidized low-density lipoprotein in atherosclerotic plaques with tagged oxidation-specific antibodies. Am J Cardiol, 2002; 90(10C):22L-27L.
[14]	Matter CM, Sehuler PK, Alseeip, et al. Molecular imaging of atherosclerotlc plaques using a human antibody against the extradomain B of fibroneetin. Cire Res, 2004, 95(12):1225-1233.
[15]	Johnson LL, Schofieht L, Donahay T, et al. ^99mTc-annexln V imaging for in vivo deteetion of atherosclerotic lesions in porcine coronary, arteries. J Nucl Med, 2005, 46(7):1186-1193.
[16]	lsobe S, Tsimikas S, Zhou J, et al. Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-densitylipoprotein receptor-deficient mice with annexin A5. J Nuel Med, 2006, 47(9):1497-1505.
[17]	Qin GM, Zhang YX, An Rui, et al. Technetium-99m labeled antisense probes uptake in vascular smooth muscle cells. Asian J Nucl Med, 2005, 5(1):8-12.
[18]	Zhang YR, Zhang YX, Cao W, et al. Uptake kitletics of ^99mTc-MAG3-antisense oligonucleotide to PCNA and effect on gene expression in vascular smooth muscle cells. J Nucl Med, 2005, 46(6):1052-1058.
[19]	Zaret BL. Second Annual Mario S. Verani, MD, Memorial lecture:nuclear cardiology, the next 10 years. J Nucl Cardiol, 2004, 11(4):393-407.

[1]	尹小花 , 张永学 . 心血管核医学分子影像研究进展. 国际放射医学核医学杂志, 2007, 31(5): 261-264.
[2]	朱羽苑 , 黄钢 . 分子核医学显像展望：多参数分子显像时代. 国际放射医学核医学杂志, 2010, 34(3): 129-134. doi: 10.3760/cma.j.issn.1673-4114.2010.03.001
[3]	杜贵永 , 朱兴建 , 付绍祥 , 李天兰 . 放射性核素显像诊断下肢深静脉血栓形成的临床研究. 国际放射医学核医学杂志, 2009, 33(6): 348-350. doi: 10.3760/cma.j.issn.1673-4114.2009.06.009
[4]	吴娇娇 , 严颖 , 卫华 . 放射性核素显像在甲状旁腺功能亢进症诊断中的研究进展. 国际放射医学核医学杂志, 2023, 47(8): 503-508. doi: 10.3760/cma.j.cn121381-202211001-00326
[5]	叶敏 , 张永学 , 夏晓天 . 正电子放射性核素显像在肾癌诊断中的研究进展. 国际放射医学核医学杂志, 2020, 44(9): 575-581. doi: 10.3760/cma.j.cn121381-201905013-00067
[6]	王荣福 . 细胞凋亡的放射性核素分子功能显像应用进展. 国际放射医学核医学杂志, 2007, 31(4): 201-204.
[7]	白剑强 , 夏群 , 胡永成 . 放射性核素骨显像在脊柱转移瘤诊断中的价值. 国际放射医学核医学杂志, 2011, 35(1): 28-30. doi: 10.3760/cma.j.issn.1673-4114.2011.01.008
[8]	邓玮玮 , 张春银 . 放射性核素显像在帕金森病鉴别诊断中的应用. 国际放射医学核医学杂志, 2017, 41(2): 132-136. doi: 10.3760/cma.j.issn.1673-4114.2017.02.010
[9]	刘晓梅 , 魏玲格 , 张芳 . 以血管生成为分子靶点的放射性核素显像分子探针在肿瘤个体化用药中的应用. 国际放射医学核医学杂志, 2017, 41(5): 363-369. doi: 10.3760/cma.j.issn.1673-4114.2017.05.011
[10]	刘岩 , 杨爱民 , 欧阳雁 , 高蕊 , 程虎 , 乔友梅 , 张芬茹 . 放射性核素唾液腺显像及抗核抗体联合检查在干燥综合征中的诊断价值. 国际放射医学核医学杂志, 2014, 38(4): 219-222. doi: 10.3760/cma.j.issn.1673-4114.2014.04.003

点击查看大图

计量

文章访问数: 1355
HTML全文浏览量: 72
PDF下载量: 2

动脉粥样硬化的分子核医学研究进展

430022 武汉, 华中科技大学同济医学院附属协和医院核医学科, 湖北省分子影像学重点实验室

收稿日期: 2007-04-28

关键词:

摘要: 动脉粥样硬化涉及到全身多处重要的动脉,是导致成人死亡的主要原因之一.早期诊断动脉粥样硬化斑块尤其是不稳定斑块具有重要的临床意义.该疾病病理生理学的不断发展,显示出包括"金标准"X射线血管造影在内的常用显像方法的一些不足以及对更加完善的显像技术的需求.分子核医学技术利用核素标记参与动脉粥样硬化形成的中间物质或其表面的血栓进行显像,无创伤性地检测斑块的数量、进展程度、分布和组成,为早期发现动脉粥样硬化提供了可靠依据.